TY - JOUR
T1 - The role of complement in arterial hypertension and hypertensive end organ damage
AU - Wenzel, Ulrich O.
AU - Kemper, Claudia
AU - Bode, Marlies
N1 - Publisher Copyright:
© 2020 The British Pharmacological Society
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6/25
Y1 - 2020/6/25
N2 - Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage.
AB - Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage.
UR - http://www.scopus.com/inward/record.url?scp=85089685772&partnerID=8YFLogxK
U2 - 10.1111/bph.15171
DO - 10.1111/bph.15171
M3 - Scientific review articles
C2 - 32585035
AN - SCOPUS:85089685772
SN - 0007-1188
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
ER -